Research Topics
Genomes and GenesSpecies | Allan HildesheimSummaryAffiliation: National Institutes of Health Country: USA Publications
| Collaborators
|
Detail Information
Publications
Invited commentary: Epstein-Barr virus-based screening for the early detection of nasopharyngeal carcinoma: a new frontierAllan Hildesheim
Infectious and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA
Am J Epidemiol 177:251-3. 2013....
Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factorsAllan Hildesheim
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA
Semin Cancer Biol 22:107-16. 2012....
High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident diseasePatti E Gravitt
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Int J Cancer 121:2787-93. 2007..The extent to which these observations can be translated into clinical practice must be rigorously examined in the context of the method of viral load measurement and the type-specific differences observed for incident >/=CIN2...- Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohortMahboobeh Safaeian
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20852, USA
J Natl Cancer Inst 102:1794-804. 2010..In a large prospective cohort, we assessed the role of C trachomatis in cervical premalignancy and addressed confounding by HPV... - Rapid clearance of human papillomavirus and implications for clinical focus on persistent infectionsAna Cecilia Rodriguez
Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, EPS, Rm 5032, Rockville, MD 20852, USA
J Natl Cancer Inst 100:513-7. 2008..These findings suggest that the medical community should emphasize persistence of cervical HPV infection, not single-time detection of HPV, in management strategies and health messages... - A comparison of cervical and vaginal human papillomavirusPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892 7234, USA
Sex Transm Dis 34:849-55. 2007..Previous studies have failed to present data on or detect a broad spectrum of HPV genotypes and/or have not carefully sampled the vagina, instead relying on self-collection that is likely contaminated with cervical cells... - Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopyCarolina Porras
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
Int J Cancer 130:1879-87. 2012..Our data support the need for a nonvisual diagnostic method to guide management and treatment of HPV-positive women... - Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancerMahboobeh Safaeian
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America
PLoS ONE 7:e33619. 2012..Host genetic factors might affect the risk of progression from infection with carcinogenic human papillomavirus (HPV), the etiologic agent for cervical cancer, to persistent HPV infection, and hence to cervical precancer and cancer... - Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancerSophia S Wang
Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Rm 5104, Rockville, MD 20852 7234, USA
J Infect Dis 199:20-30. 2009..We examined host genetic factors to identify those more common in individuals whose human papillomavirus (HPV) infections were most likely to persist and progress to cervical intraepithelial neoplasia grade 3 (CIN3) and cancer... - Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormalityMelinda Butsch Kovacic
Division of Cancer Epidemiology and Genetics and Cancer Prevention Fellowship Program, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA
Cancer Res 66:10112-9. 2006..The lack of evident severe abnormalities associated with HPV18 and related HPV types might have implications for screening for poorly detected glandular and alpha7-related lesions... - Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisitedJill Koshiol
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852 7248, USA
Cancer Epidemiol Biomarkers Prev 18:1631-7. 2009..Although genetic variation in TP53 might affect the natural history of HPV and cervical cancer, further work is needed to elucidate the possible mechanism... - Age-related changes of the cervix influence human papillomavirus type distributionPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute NIH, 6120 Executive Boulevard, Bethesda, MD 20892 7234, USA
Cancer Res 66:1218-24. 2006..These patterns need to be confirmed in other studies and populations. We suggest that these genetically distinct groups of HPV types may differ in tissue preferences, which may contribute to their differences in carcinogenic potential... - Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancerPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892 7234, USA
Int J Cancer 125:1649-56. 2009.... - Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical diseaseAnil K Chaturvedi
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, EPS 7072 Rockville, MD 20852, USA
J Infect Dis 203:910-20. 2011..We investigated coinfection patterns for 25 human papillomavirus (HPV) types and assessed the risk conferred by multiple HPV types toward cervical disease... - A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasiaMark Schiffman
Divisions of Cancer Epidemiology and Genetics and Cancer Prevention, National Cancer Institute, Bethesda, Maryland 20852, USA
Cancer Res 70:3159-69. 2010..Larger viral genomic studies are warranted, especially to identify the genetic basis for HPV16's unique carcinogenicity... - Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC familiesKelly J Yu
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland, USA
Clin Cancer Res 17:1906-14. 2011..We examined the risk associated with EBV markers and their clinical utility to identify NPC susceptibles within high-risk NPC families... - Cancer patterns in nasopharyngeal carcinoma multiplex families in TaiwanKelly J Yu
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD 20852, USA
Int J Cancer 124:1622-5. 2009..0. Analysis of the largest NPC multiplex family study to date confirms the presence of coaggregation of NPC within families in Taiwan but does not provide evidence for a broader familial syndrome involving NPC and other tumors... - Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancerPhilip E Castle
Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 7234, USA
J Infect Dis 203:814-22. 2011..Detailed descriptions of long-term persistence of human papillomavirus (HPV) in the absence of cervical precancer are lacking... - Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa RicaSophia S Wang
Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, EPS MSC 7234, Bethesda, MD 20892 7234, USA
Cancer Epidemiol Biomarkers Prev 13:1355-60. 2004..Whereas our data support the diagnostic potential for p16INK4a, further prospective studies with detailed follow-up determining the prognostic capacity of this marker are needed... - Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infectionsMahboobeh Safaeian
Division of Cancer Epidemiology and Genetics, Infections and Immunoepidemiology Branch, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, Ste 550, Rockville, MD 20852, USA
J Natl Cancer Inst 102:1653-62. 2010..Infection with human papillomavirus (HPV) 16 or HPV18 elicits an antibody response, but whether the elicited antibodies protect women against subsequent infection by a homologous HPV type compared with seronegative women is unknown... - Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatmentAimee R Kreimer
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Rockville, MD, USA
Int J Cancer 131:211-8. 2012..Thus, persistence of HPV infection a median of six years after treatment was uncommon but, when present, posed a substantial risk of subsequent CIN2+. Serial follow-up data from other studies would further strengthen these conclusions... - Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinomaMelinda Butsch Kovacic
Hormonal and Reproductive Epidemiology Branch, National Cancer Institute, 6120 Executive Boulevard, Room 7101, Bethesda, MD 20853, USA
Cancer Epidemiol Biomarkers Prev 14:2673-7. 2005.... - Determinants and correlation of systemic and cervical concentrations of total IgA and IgGMahboobeh Safaeian
Division of Cancer Epidemiology and Genetics, Infections and Immunoepidemiology Branch, National Cancer Institute, 6120 Executive Boulevard, Suite 550, Rockville, MD 20852, USA
Cancer Epidemiol Biomarkers Prev 18:2672-6. 2009..17 and 0.16, respectively). The lack of correlation between systemic and cervical total IgA and IgG suggests that systemic concentrations are not reflective of cervical levels... - Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine TrialAimee R Kreimer
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Lancet Oncol 12:862-70. 2011..Human papillomavirus (HPV) 16 and 18 infections cause most cases of anal cancer. We assessed efficacy of an AS04-adjuvanted HPV 16 and HPV 18 vaccine against anal infection with HPV 16, HPV 18, or both (HPV 16/18)... - Comparison of two PCR-based human papillomavirus genotyping methodsPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Room 5004, EPS MSC 7234, Bethesda, MD 20892 7234
J Clin Microbiol 46:3437-45. 2008..Both approaches are suitable for monitoring the impact of HPV16/18 vaccines in clinical trials... - The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual lifeAna Cecilia Rodriguez
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Rockville, Maryland 20859, USA
Sex Transm Dis 34:494-502. 2007..We wanted to explore early HPV natural history and CIN 3 prospectively... - A population-based study of vaginal human papillomavirus infection in hysterectomized womenPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 7234, USA
J Infect Dis 190:458-67. 2004..e., A3/A4/A15) may have a predilection for vaginal epithelium... - A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa RicaPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 7234, USA
J Infect Dis 191:1808-16. 2005..In some populations, HPV prevalence demonstrates a second peak in older women. Longitudinal data may help to explain this second peak... - Alterations of T-cell surface markers in older women with persistent human papillomavirus infectionAna Cecilia Rodriguez
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Int J Cancer 128:597-607. 2011..Whether phenotypic alterations observed predispose to HPV persistence or result from it should be the focus of future studies... - Determinants of seropositivity among HPV-16/18 DNA positive young womenCarolina Porras
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
BMC Infect Dis 10:238. 2010..We evaluated determinants of seropositivity among 646 women infected with HPV-16 and/or HPV-18... - Longitudinal analysis of carcinogenic human papillomavirus infection and associated cytologic abnormalities in the Guanacaste natural history study: looking ahead to cotestingSarah Coseo Markt
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
J Infect Dis 205:498-505. 2012..The aim of this analysis was to assess the longitudinal relationship of abnormal cytology and HPV positivity in a 7-year prospective study of 2500 women in Guanacaste, Costa Rica... - Distribution of Epstein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in TaiwanXiaohong Yang
Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20852, USA
Int J Cancer 118:780-4. 2006.... - Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa RicaFelipe A Castro
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
J Infect Dis 206:1103-10. 2012..Anal cancer is caused by human papillomavirus (HPV), yet little is known about anal HPV infection among healthy young women... - Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccineAimee R Kreimer
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, EPS 7084, Rockville, MD 20852, USA
J Natl Cancer Inst 103:1444-51. 2011..Three-dose regimens for human papillomavirus (HPV) vaccines are expensive and difficult to complete, especially in settings where the need for cervical cancer prevention is greatest... - Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa RicaSarah Coseo
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 6120 Executive Blvd, EPS, Room 7079, Rockville, MD 20852, USA
Sex Transm Dis 37:706-14. 2010..We investigated HPV16 and 18 seroepidemiology among young, unvaccinated women aged between 18 and 25... - PCR testing of pooled longitudinally collected cervical specimens of women to increase the efficiency of studying human papillomavirus infectionPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Room 7074, 6120 Executive Boulevard, EPS MSC 7234, Bethesda, MD 20892 7234, USA
Cancer Epidemiol Biomarkers Prev 14:256-60. 2005..3% (95% CI, 74.7-91.4%), respectively. We conclude that pooling specimens and testing by PCR may be useful for discriminating HPV DNA-positive from completely negative specimen sets in women who are likely to have been HPV DNA-negative.>.. - Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasiaLisa Mirabello
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA
Int J Cancer 132:1412-22. 2013..Higher methylation in CIN2+ cases was not explained by higher viral load. We conclude that elevated levels of HPV16 DNA methylation may be useful to predict concurrently diagnosed as well as future CIN2+... - A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History StudyNicolas Wentzensen
National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
J Infect Dis 204:94-102. 2011..A competitive Luminex Immunoassay (cLIA) has been developed to measure neutralizing antibodies against human papillomavirus (HPV) types 6, 11, 16 and 18... - Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican populationLisa Mirabello
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, 6120 Executive Blvd, EPS 7101, Rockville, MD 20892, USA
J Natl Cancer Inst 104:556-65. 2012.... - Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trialAllan Hildesheim
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
JAMA 298:743-53. 2007..Viruslike particle human papillomavirus (HPV) vaccines were designed to prevent HPV infection and development of cervical precancers and cancer. Women with oncogenic HPV infections might consider vaccination as therapy... - Direct comparison of HPV16 serological assays used to define HPV-naïve women in HPV vaccine trialsMahboobeh Safaeian
Division of Cancer Epidemiology and Genetics, Infections and Immunoepidemiology Branch, National Cancer Institute, NIH, Bethesda, MD, USA
Cancer Epidemiol Biomarkers Prev 21:1547-54. 2012..Some of the variation in estimated vaccine efficacies may be due to the differences in these assays used to define the HPV-naïve subgroups. To guide the interpretation of published results, we compared these assays... - A large, population-based study of age-related associations between vaginal pH and human papillomavirus infectionMegan A Clarke
Division of Cancer Epidemiology and Genetics, DHHS, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
BMC Infect Dis 12:33. 2012..We examined vaginal pH and the risk of HPV infection, cytological abnormalities, and C. trachomatis infection... - Evaluation of risk factors for nasopharyngeal carcinoma in high-risk nasopharyngeal carcinoma families in TaiwanXiaohong Rose Yang
Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Room 7014, Bethesda, MD 20852, USA
Cancer Epidemiol Biomarkers Prev 14:900-5. 2005..The results from the two methods were similar indicating that the risk estimates from conditional logistic regression were unbiased... - Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in TaiwanAmy Pickard
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Int J Cancer 111:117-23. 2004..Unaffected individuals from high-risk NPC families have elevated anti-EBV IgA antibody titers. The etiologic and clinical implications of this finding remain to be established... - HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assaysShih Wen Lin
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America
PLoS ONE 8:e53067. 2013.... - Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposureSarah E Coseo
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20852, USA
Sex Transm Dis 38:976-82. 2011..Overall performance of these assays, as a measure of HPV exposure, has not been evaluated... - The carcinogenicity of human papillomavirus types reflects viral evolutionMark Schiffman
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MA, USA
Virology 337:76-84. 2005..These results present several clear clues and research directions in our ongoing efforts to understand HPV carcinogenesis... - A study of the impact of adding HPV types to cervical cancer screening and triage testsMark Schiffman
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892 7234, USA
J Natl Cancer Inst 97:147-50. 2005..The minimal increases in sensitivity and in negative predictive value achieved by adding HPV types to DNA tests must be weighed against the projected burden to thousands of women falsely labeled as being at high risk of cervical cancer... - Factors associated with fluctuations in IgA and IgG levels at the cervix during the menstrual cycleMahboobeh Safaeian
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
J Infect Dis 199:455-63. 2009..The objective of this analysis was to describe patterns and determinants of cervical immunoglobulin A (IgA) and G (IgG) levels during the menstrual cycle... - Assessment of human papillomavirus in lung tumor tissueJill Koshiol
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892 7248, USA
J Natl Cancer Inst 103:501-7. 2011..Lung cancer kills more than 1 million people worldwide each year. Whereas several human papillomavirus (HPV)-associated cancers have been identified, the role of HPV in lung carcinogenesis remains controversial... - Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in TaiwanKelly J Yu
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA
Hum Immunol 70:910-4. 2009..This finding requires replication in larger studies... - Lack of heterogeneity of HPV16 E7 sequence compared with HPV31 and HPV73 may be related to its unique carcinogenic propertiesMahboobeh Safaeian
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA
Arch Virol 155:367-70. 2010..The lack of heterogeneity of HPV16 E7 suggests high evolutionary purifying selection that might be related to the unique carcinogenicity of HPV16... - Evaluation of the association with cervical cancer of polymorphisms in syndecan-1, a heparan sulfate proteoglycan involved with viral cell entryKelly J Yu
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, 6120 Executive Boulevard, Suite 550, Bethesda, MD 20852, USA
Cancer Epidemiol Biomarkers Prev 16:2504-8. 2007..S. Study. Our results indicate a lack of association between SDC-1 polymorphisms and risk of squamous cell carcinomas of the cervix. An association between SDC-1 Pro-27 polymorphism and cervical adenocarcinoma cannot be ruled out... - Improved genetic association tests for an ordinal outcome representing the disease progression processHong Zhang
Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Bethesda, MD 20892, USA
Genet Epidemiol 35:499-505. 2011..As a demonstration, we applied the considered tests to a genetic association study of cervical cancer... - Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen lociMary Carrington
Basic Research Program, Laboratory of Genomic Diversity, Science Applications International Corporation Frederick, Inc, National Cancer Institute, Frederick, MD 21702, USA
J Exp Med 201:1069-75. 2005.... - Characterization of ELISA detection of broad-spectrum anti-Epstein-Barr virus antibodies associated with nasopharyngeal carcinomaCindy Chang
Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Rockville, Maryland 20892, USA
J Med Virol 85:524-9. 2013..In conclusion, a large number of EBV markers can be measured reliably in serum samples using peptide-based anti-EBV ELISAs... - Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trialsSholom Wacholder
Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Rockville, MD 20852, USA
BMJ 340:c712. 2010..To assess whether vaccination against human papillomavirus (HPV) increases the risk of miscarriage... - Pathological characteristics of cervical adenocarcinoma in a multi-center US-based studySophia S Wang
Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, Bethesda, MD 20852 7234, USA
Gynecol Oncol 103:541-6. 2006..We report a detailed pathology review of cervical adenocarcinoma subtypes, comparing growth patterns and appearance of non-neoplastic epithelium to inform possible clues for disease progression and early detection... - The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisalCindy M Chang
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, EPS 7074, Rockville, MD 20892, USA
Virus Res 143:209-21. 2009.... - Comparison of ophthalmic sponges for measurements of immune markers from cervical secretionsPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 7234, USA
Clin Diagn Lab Immunol 11:399-405. 2004..These findings require confirmation... - Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin LevelsTroy J Kemp
HPV Immunology Laboratory, SAIC Frederick, Inc, NCI Frederick Frederick, MD, USA
Front Oncol 2:61. 2012..Future studies should examine whether antigen-specific antibody responses induced by vaccination correlate across mucosal sites... - Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000Sophia S Wang
Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892 7234, USA
Cancer 100:1035-44. 2004..Therefore, the authors assessed the differential incidence rates of squamous cell carcinoma (SCC) and adenocarcinoma (AC) of the cervix by race and disease stage for the past 25 years... - Genes involved in DNA repair and nitrosamine metabolism and those located on chromosome 14q32 are dysregulated in nasopharyngeal carcinomaLori E Dodd
National Cancer Institute, 6120 Executive Boulevard, Room 7062, Rockville, MD 20852, USA
Cancer Epidemiol Biomarkers Prev 15:2216-25. 2006..Our results suggest that nitrosamine activation and DNA repair are important in NPC. The consistent down-regulation of expression on chromosome 14q32 suggests loss of heterozygosity in this region... - Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa RicaMahboobeh Safaeian
Division of Cancer Epidemiology and Genetics, Hormonal and Reproductive Epidemiology Branch, National Cancer Institute, 6120 Executive Boulevard, Suite 550, Rockville, MD 20852, USA
J Clin Microbiol 45:1447-54. 2007..The crude agreement between the two assays was 88%, with a kappa value of 0.75 (95% confidence limits, 0.73 to 0.76). We observed very good agreement between HC2 and SPF(10)-LiPA for carcinogenic HPV type detection... - Human papillomavirus infection and the primary and secondary prevention of cervical cancerDouglas R Lowy
Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
Cancer 113:1980-93. 2008..The manner in which vaccination and screening programs are integrated will need to be considered carefully so that they are efficient in reducing the overall incidence of cervical cancer... - CD83 polymorphisms and cervical cancer riskKelly J Yu
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD 20852, USA
Gynecol Oncol 114:319-22. 2009.... - The epidemiology of oral HPV infection among a multinational sample of healthy menAimee R Kreimer
National Cancer Institute, NIH, Bethesda, Maryland, USA
Cancer Epidemiol Biomarkers Prev 20:172-82. 2011..Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men... - Comparison of mRNA and protein measures of cytokines following vaccination with human papillomavirus-16 L1 virus-like particlesFatma M Shebl
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, EPS 7074, Rockville, MD 20852, USA
Cancer Epidemiol Biomarkers Prev 19:978-81. 2010..Few studies have directly compared results obtained using gene expression and multiplex protein assays for corresponding gene products...